Rat And Mouse Model Market To Reach $3.58 Billion By 2030

Rat And Mouse Model Market Growth & Trends

The global rat and mouse model market is anticipated to reach USD 3.58 billion by 2030 and is anticipated to expand at a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Humanized mouse and rat models are used in biological and medical research due to functional human genes, tissues, cells, and organs. In health and clinical settings, these mouse & rat prototypes are utilized to replicate the human immune system. Furthermore, humanized mouse and rat prototypes are used for basic research, evaluating the safety of large-molecule medicines, simulating some human-specific infectious diseases, along with testing the efficacy of immunotherapy approaches.

The use of mouse & rat prototypes for the identification of immunodeficiency disorders, tumors, and various other rare diseases, along with an increase in R&D activities carried out by healthcare and biotechnology companies, as well as continuous funding and interventions from governments and private sectors for mouse & rat model research, are driving the global market. Furthermore, technological advancements for developing animal models are anticipated to spur market growth. Companies are adopting advanced technologies to develop better models. For instance, in October 2023, Taconic Biosciences, a major company operating in the industry, announced the ExprssMODEL CRISPR Platform, which can advance the development and manufacturing of mouse models. This platform can eliminate the need for an expansion breeding step and saves a minimum three months in the overall study timeline. Such developments are anticipated to drive the industry’s growth over the forecast period.

Furthermore, players operating in the industry are undertaking several initiatives like partnerships, collaborations, acquisitions, and mergers to strengthen their market position. For instance, in April 2023, an ingenious targeting laboratory, a provider of custom genetically modified rat, mouse, and rabbit models, partnered with Shanghai Model Organisms Center (SMOC) to distribute SMOC’s validated off-the-shelf mouse models in Europe and North America. Such collaborations are expected to increase the accessibility of animal models, which can drive market growth in the coming years.

 Request a free sample copy or view report summary: Rat And Mouse Model Market Report

Rat And Mouse Model Market Report Highlights

• The models segment dominated the model and service segment with a revenue share of 88.6% in 2023, owing to the availability of different types of rats and animal models.

• The services segment is expected to grow at the fastest CAGR over the forecast period due to the increasing focus of industry participants on offering numerous services like cryopreservation, breeding, validation, phenotyping, husbandry and rederivation, among others.

• Based on application, the cancer segment dominated the market in 2023. On the other hand, the genetic diseases segment is expected to witness the fastest growth over the forecast period.

• North America region dominated the market owing to factors such as the presence of key market players like Inotiv, Charles River Laboratories, Ozgene Pty Ltd, Taconic Biosciences and the growth in pharmaceutical as well as research sectors in this region.

• Asia Pacific is expected to register the fastest growth over the forecast period due to several companies expanding their presence in Asia Pacific countries like Japan.

• Major market players operating in the global rat and mouse models market include Charles River Laboratories, The Jackson Laboratory, Cyagen, genOway, Inotiv, Janvier Labs, Taconic Biosciences, Inc., Biomedical Research Models (Biomere), Hera Biolabs, Kind Lab, and Ozgene Pty Ltd. among others

Rat And Mouse Model Market Segmentation

Grand View Research has segmented global rat and mouse model market on the basis of model and service, end-use, application, and region:

Rat And Mouse Model And Service Outlook (Revenue, USD Billion, 2018 - 2030)

• Model

  • Inbred

    • Knockout

    • Knock-in

    • Others

  • Outbred

    • Knockout

    • Knock-in

    • Others

• Service

  • Cryopreservation

  • Breeding

  • Rederivation

  • Genetic testing

  • Quarantine depending

  • Others

Rat And Mouse Model Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Cardiovascular diseases

• Genetic diseases

• Cancer

• Infectious diseases

  • COVID-19

  • Others

• Transplantation

• Others

Rat And Mouse Model End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Pharmaceutical & Biotechnology companies

• Academic and research facilities

• Contract research & manufacturing organizations

Rat And Mouse Model Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Rat And Mouse Model Market

• Charles River Laboratories

• The Jackson Laboratory

• Cyagen

• genOway

• Inotiv

• Janvier Labs

• Taconic Biosciences, Inc.

• Biomedical Research Models (Biomere)

• Hera Biolabs

• Kind Lab

• Ozgene Pty Ltd